Let's say that a human is homozygous for a mutation in the IRE-BP gene that changed the structure of the iron regulatory protein in such a way that it could not bind iron, but still could bind to mRNA. How would this mutation affect the regulation of the transferrin receptor mRNAS ?
A.It would cause the transferrin receptor gene to always be expressed
B.It would prevent the transferrin receptor gene from being expressed
C.It would cause iron to increase inside the cell
D.A and C
E. B and C
When iron bind with IRE it become bind with fransferrin receptor gene and prevent expression.
IRE has a specific sequence for iron binding ability. If mutation occur in these region then it loss function of iron binding.
Transferrin gene help into removal of extra irons removal from the cell.
So as the iron not bind with IRE it may bind prevent the expreesion of transferrin receptor but it not able to removal of iron.
Your answer is E.
It would prevent the rltransferrin receptor gene from being expressed
It would cause iron to increase inside the cell
Thanks
Let's say that a human is homozygous for a mutation in the IRE-BP gene that changed...
Genetics Worksheet Week 3: Gene Regulation and Epigenetics 1. Duchenne muscular dystrophy is caused by a mutation in a gene that is 2.5 million nucleotides in length and encodes a protein called dystrophin. The dystrophin protein itself is 3684 amino acids in length. Calculate below the approximate size of the mRNA that encodes dystrophin. Approximately what percentage of the gene that encodes dystrophin is intron sequence? The human genome encodes a much greater variety and number of proteins than the...
please help!!
transcription? How could the presence of a hormone in the blood have an effect on this structure? 6 points 3. What is an enhancer region and why is it important in the regulation of eukaryotic Contents Cancer Genes that cause cancer are called oncogenes. d. promoter genes. a. operator genes. b. pseudogenes.c 2A mutation in which of the following genes would be LEAST likely lead to a cancer? a. growth hormone gene b. growth hormone receptor gene c....
Please read the article bellow and discuss the shift in the
company's approach to genetic analysis. Please also discuss what
you think about personal genomic companies' approaches to research.
Feel free to compare 23andMe's polices on research with another
company's. Did you think the FDA was right in prohibiting 23andMe
from providing health information?
These are some sample talking points to get you thinking about
the ethics of genetic research in the context of Big Data. You
don't have to...